US Stock MarketDetailed Quotes

BCAB BioAtla

Watchlist
  • 2.165
  • +0.105+5.10%
Trading Nov 7 10:47 ET
104.65MMarket Cap-997P/E (TTM)

BioAtla Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
20.34%-19.19M
-36.08%-30.83M
-15.04%-104.02M
-22.90%-29.92M
-13.86%-27.35M
-42.39%-24.09M
9.87%-22.65M
-45.34%-90.42M
-16.22%-24.35M
-88.72%-24.02M
Net income from continuing operations
41.06%-21.07M
15.39%-23.23M
-15.95%-123.46M
2.24%-26.93M
-29.27%-33.33M
-23.68%-35.75M
-13.22%-27.46M
-11.61%-106.48M
-17.76%-27.54M
-12.42%-25.78M
Operating gains losses
----
----
-84.62%2K
----
----
----
----
101.90%13K
--7K
--0
Depreciation and amortization
-21.03%229K
-18.09%240K
1.83%1.22M
23.49%368K
-10.00%270K
0.69%290K
-6.39%293K
-9.85%1.2M
-5.10%298K
-21.05%300K
Change In working capital
-111.00%-846K
-1,227.25%-10.13M
1,530.66%4.68M
-900.82%-6.11M
203.20%2.19M
-1.99%7.69M
118.62%899K
-96.13%287K
63.76%-610K
-134.56%-2.13M
-Change in prepaid assets
168.75%1.12M
59.16%-860K
99.58%-11K
388.30%1.29M
237.01%385K
231.23%416K
7.55%-2.11M
-1,001.69%-2.61M
-79.28%265K
-124.87%-281K
-Change in payables and accrued expense
-126.21%-1.95M
-384.93%-8.98M
54.91%5.28M
-886.26%-7.25M
214.97%1.96M
-10.36%7.42M
229.51%3.15M
-57.32%3.41M
74.23%-735K
-133.21%-1.7M
-Change in other working capital
87.76%-18K
-102.74%-296K
-15.59%-593K
-7.14%-150K
-6.38%-150K
-26.72%-147K
-25.86%-146K
-54.98%-513K
-27.27%-140K
-28.18%-141K
Cash from discontinued investing activities
Operating cash flow
20.34%-19.19M
-36.08%-30.83M
-15.04%-104.02M
-22.90%-29.92M
-13.86%-27.35M
-42.39%-24.09M
9.87%-22.65M
-45.34%-90.42M
-16.22%-24.35M
-88.72%-24.02M
Investing cash flow
Cash flow from continuing investing activities
0
0
63.02%-98K
74.19%-8K
56.90%-25K
90.96%-15K
-400.00%-50K
71.32%-265K
65.17%-31K
41.41%-58K
Net PPE purchase and sale
--0
--0
63.02%-98K
74.19%-8K
56.90%-25K
90.96%-15K
-400.00%-50K
71.32%-265K
65.17%-31K
41.41%-58K
Cash from discontinued investing activities
Investing cash flow
--0
--0
63.02%-98K
74.19%-8K
56.90%-25K
90.96%-15K
-400.00%-50K
71.32%-265K
65.17%-31K
41.41%-58K
Financing cash flow
Cash flow from continuing financing activities
95.65%225K
88.79%-13K
-99.87%77K
-99.81%119K
57.29%-41K
325.49%115K
71.36%-116K
-11.94%61.21M
1,680.48%61.77M
-100.13%-96K
Net common stock issuance
----
----
--0
----
----
----
----
-13.12%61.68M
----
----
Proceeds from stock option exercised by employees
----
----
16.26%336K
-44.81%149K
--14K
----
----
-32.63%289K
172.73%270K
--0
Net other financing activities
67.24%-19K
88.79%-13K
65.83%-259K
83.96%-30K
42.71%-55K
17.14%-58K
71.36%-116K
60.33%-758K
---187K
---96K
Cash from discontinued financing activities
Financing cash flow
95.65%225K
88.79%-13K
-99.87%77K
-99.81%119K
57.29%-41K
325.49%115K
71.36%-116K
-11.94%61.21M
1,680.48%61.77M
-100.13%-96K
Net cash flow
Beginning cash position
-58.15%80.63M
-48.27%111.47M
-12.03%215.51M
-20.68%141.28M
-16.61%168.69M
-12.19%192.69M
-12.03%215.51M
2.67%244.98M
-34.01%178.12M
-2.56%202.29M
Current changes in cash
20.95%-18.97M
-35.15%-30.84M
-253.00%-104.04M
-179.74%-29.81M
-13.41%-27.41M
-40.00%-23.99M
10.69%-22.82M
-562.38%-29.47M
249.87%37.39M
-138.79%-24.17M
End cash Position
-63.45%61.66M
-58.15%80.63M
-48.27%111.47M
-48.27%111.47M
-20.68%141.28M
-16.61%168.69M
-12.19%192.69M
-12.03%215.51M
-12.03%215.51M
-34.01%178.12M
Free cash flow
20.39%-19.19M
-35.78%-30.83M
-14.80%-104.11M
-22.77%-29.93M
-13.69%-27.37M
-41.07%-24.11M
9.71%-22.7M
-43.63%-90.69M
-15.88%-24.38M
-87.71%-24.07M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 20.34%-19.19M-36.08%-30.83M-15.04%-104.02M-22.90%-29.92M-13.86%-27.35M-42.39%-24.09M9.87%-22.65M-45.34%-90.42M-16.22%-24.35M-88.72%-24.02M
Net income from continuing operations 41.06%-21.07M15.39%-23.23M-15.95%-123.46M2.24%-26.93M-29.27%-33.33M-23.68%-35.75M-13.22%-27.46M-11.61%-106.48M-17.76%-27.54M-12.42%-25.78M
Operating gains losses ---------84.62%2K----------------101.90%13K--7K--0
Depreciation and amortization -21.03%229K-18.09%240K1.83%1.22M23.49%368K-10.00%270K0.69%290K-6.39%293K-9.85%1.2M-5.10%298K-21.05%300K
Change In working capital -111.00%-846K-1,227.25%-10.13M1,530.66%4.68M-900.82%-6.11M203.20%2.19M-1.99%7.69M118.62%899K-96.13%287K63.76%-610K-134.56%-2.13M
-Change in prepaid assets 168.75%1.12M59.16%-860K99.58%-11K388.30%1.29M237.01%385K231.23%416K7.55%-2.11M-1,001.69%-2.61M-79.28%265K-124.87%-281K
-Change in payables and accrued expense -126.21%-1.95M-384.93%-8.98M54.91%5.28M-886.26%-7.25M214.97%1.96M-10.36%7.42M229.51%3.15M-57.32%3.41M74.23%-735K-133.21%-1.7M
-Change in other working capital 87.76%-18K-102.74%-296K-15.59%-593K-7.14%-150K-6.38%-150K-26.72%-147K-25.86%-146K-54.98%-513K-27.27%-140K-28.18%-141K
Cash from discontinued investing activities
Operating cash flow 20.34%-19.19M-36.08%-30.83M-15.04%-104.02M-22.90%-29.92M-13.86%-27.35M-42.39%-24.09M9.87%-22.65M-45.34%-90.42M-16.22%-24.35M-88.72%-24.02M
Investing cash flow
Cash flow from continuing investing activities 0063.02%-98K74.19%-8K56.90%-25K90.96%-15K-400.00%-50K71.32%-265K65.17%-31K41.41%-58K
Net PPE purchase and sale --0--063.02%-98K74.19%-8K56.90%-25K90.96%-15K-400.00%-50K71.32%-265K65.17%-31K41.41%-58K
Cash from discontinued investing activities
Investing cash flow --0--063.02%-98K74.19%-8K56.90%-25K90.96%-15K-400.00%-50K71.32%-265K65.17%-31K41.41%-58K
Financing cash flow
Cash flow from continuing financing activities 95.65%225K88.79%-13K-99.87%77K-99.81%119K57.29%-41K325.49%115K71.36%-116K-11.94%61.21M1,680.48%61.77M-100.13%-96K
Net common stock issuance ----------0-----------------13.12%61.68M--------
Proceeds from stock option exercised by employees --------16.26%336K-44.81%149K--14K---------32.63%289K172.73%270K--0
Net other financing activities 67.24%-19K88.79%-13K65.83%-259K83.96%-30K42.71%-55K17.14%-58K71.36%-116K60.33%-758K---187K---96K
Cash from discontinued financing activities
Financing cash flow 95.65%225K88.79%-13K-99.87%77K-99.81%119K57.29%-41K325.49%115K71.36%-116K-11.94%61.21M1,680.48%61.77M-100.13%-96K
Net cash flow
Beginning cash position -58.15%80.63M-48.27%111.47M-12.03%215.51M-20.68%141.28M-16.61%168.69M-12.19%192.69M-12.03%215.51M2.67%244.98M-34.01%178.12M-2.56%202.29M
Current changes in cash 20.95%-18.97M-35.15%-30.84M-253.00%-104.04M-179.74%-29.81M-13.41%-27.41M-40.00%-23.99M10.69%-22.82M-562.38%-29.47M249.87%37.39M-138.79%-24.17M
End cash Position -63.45%61.66M-58.15%80.63M-48.27%111.47M-48.27%111.47M-20.68%141.28M-16.61%168.69M-12.19%192.69M-12.03%215.51M-12.03%215.51M-34.01%178.12M
Free cash flow 20.39%-19.19M-35.78%-30.83M-14.80%-104.11M-22.77%-29.93M-13.69%-27.37M-41.07%-24.11M9.71%-22.7M-43.63%-90.69M-15.88%-24.38M-87.71%-24.07M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data